Issues related to drug pricing; Issues related to H.R. 7142/S. 3832 - Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.
2025 · 1st Quarter (Jan 1 - Mar 31)
VERTEX PHARMACEUTICALS
Filed by TIBER CREEK GROUP.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 19, 2025
- Income
- $80,000.00
- Expenses
- Not reported
- Registrant
- TIBER CREEK GROUP
- Client
- VERTEX PHARMACEUTICALS
- Filing UUID
- 192f44a6-d6d9-475d-9456-09a7257455bf
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to opioid alternatives.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.